The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings

Affiliations

Editorial

Amir Sherif. Transl Androl Urol. 2018 Jun.

. 2018 Jun;7(3):508-510.

doi: 10.21037/tau.2018.06.04.

¹ Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
Booth CM, Karim S, Brennan K, Siemens DR, Peng Y, Mackillop WJ. Booth CM, et al. Urol Oncol. 2018 Mar;36(3):89.e13-89.e20. doi: 10.1016/j.urolonc.2017.11.015. Epub 2017 Dec 15. Urol Oncol. 2018. PMID: 29254673

1. Booth CM, Karim S, Brennan K, et al. Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing? Urol Oncol 2018;36:89.e13-89.e20. 10.1016/j.urolonc.2017.11.015 - DOI - PubMed
1. Dogan S, Hennig M, Frank T, et al. Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice. Urol Int 2018. [Epub ahead of print]. 10.1159/000487405 - DOI - PubMed
1. Üçer O, Albaz AC, Atag E, et al. The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey. Urol J 2016;13:2841-4. - PubMed
1. Available online: https://www.cancercentrum.se/globalassets/cancerdiagnoser/urinvagar/urin...
1. Available online: https://www.cancercentrum.se/globalassets/cancerdiagnoser/urinvagar/urin...